Research Studies

Researchers: C₂N partners with many academic and research institutions interested in using C₂N neurodegenerative biomarkers in pre-clinical and clinical research studies (e.g., Alzheimer’s disease).  If you wish to discuss C₂N biomarkers or the use of the Precivity tests in your research studies, please complete the following form.  A C₂N representative will be in contact once your information has been received.

For immediate questions, please reach out at research@c2n.com or call 1.877.226.3424.

 

* = Mandatory fields